IOVAIOVANCE BIOTHERAPEUTICS, INC.vs its industry peers
A metric-by-metric comparison of IOVANCE BIOTHERAPEUTICS, INC. against SIC 2836 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Empresa | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| IOVAEsta | $4.6B#2 | — | 6.3x#8 | 17.6x#3 | 60.6%#5 | -5.1%#8 | -153.1%#3 | -53.1%#5 | — | — | — | — |
| IMTX | $1.2B#5 | — | — | — | — | — | — | — | — | — | — | — |
| IMVT | $7.6B#1 | — | 10.4x#9 | — | — | -22.2%#11 | — | -68.8%#6 | — | — | — | — |
| INAB | $11M#14 | — | 0.6x#2 | — | — | 36.1%#6 | — | -105.9%#8 | — | — | — | — |
| INBX | $1.6B#4 | — | — | 1246.3x#5 | 550.0%#2 | -108.3%#13 | -10386.5%#4 | — | — | — | 313.1%#1 | — |
| INKT | $59M#11 | — | — | — | — | -15.9%#10 | — | — | — | — | — | — |
| INMB | $65M#10 | — | 3.2x#7 | 1304.4x#6 | 257.1%#3 | -9.5%#9 | -94766.0%#6 | -225.9%#10 | -607.3%#2 | — | — | — |
| INTS | $13M#13 | — | 1.4x#5 | — | — | 28.7%#7 | — | -126.0%#9 | — | — | — | — |
| IPHA | $180M#8 | — | — | — | — | — | — | — | — | — | — | — |
| IPSC | $333M#6 | — | 1.4x#6 | 3.1x#1 | 1556.8%#1 | 92.4%#3 | -15.8%#1 | -4.1%#3 | -9.3%#1 | — | — | — |
| IVVD | $224M#7 | — | 1.2x#3 | 4.2x#2 | 110.5%#4 | 69.1%#4 | -104.0%#2 | -29.0%#4 | — | — | — | — |
| JSPR | $21M#12 | — | 14.8x#10 | — | — | 100.0%#1 | — | -0.0%#1 | — | — | -75.7%#4 | — |
| JSPRW | $296144#15 | — | 0.2x#1 | — | — | 100.0%#1 | — | -0.0%#1 | — | — | -91.1%#5 | — |
| KLRS | $75M#9 | — | 1.3x#4 | 455.9x#4 | — | 37.2%#5 | -27970.9%#5 | -75.3%#7 | — | — | -28.5%#3 | — |
| KOD | $2.1B#3 | — | 33.6x#11 | — | — | -30.5%#12 | — | -376.4%#11 | — | — | 232.3%#2 | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2836). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. Esta tabla agotó el tiempo durante su construcción, por lo que cubre parte del grupo; los rangos son solo dentro de las filas mostradas y se completará en breve. Table built 2026-09-19.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice